The company recalled various cystoscopes, ureteroscopes, cystourethroscopes and ureterorenoscopes April 1 after identifying several reprocessing issues. Karl Storz is instructing healthcare providers to discontinue all high-level disinfection methods for the endoscopes. Liquid chemical sterilization should also not be used for some devices.
“The FDA will continue to work with Karl Storz to evaluate the root cause of reprocessing failures and to ensure that an adequate supply of urological endoscopes are available for users and patient care,” the agency said.
The company will also provide updated sterilization instructions for affected endoscopes.
Learn more here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.